Filing Details

Accession Number:
0001415889-13-000635
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-04-03 18:08:41
Reporting Period:
2013-04-01
Filing Date:
2013-04-03
Accepted Time:
2013-04-03 18:08:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070494 Acadia Pharmaceuticals Inc ACAD Pharmaceutical Preparations (2834) 061376651
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1368190 Roger Mills 3911 Sorrento Valley Blvd
San Diego CA 92121
Evp, Development And Cmo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-04-01 58,584 $7.69 14,017 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2012.
  2. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.59 to $7.90 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.
  3. All shares reflected in the this filing, including the shares sold and the remaining 14,017 shares, were acquired by Dr. Mills under the ACADIA Pharmaceuticals Employee Stock Purchase Plan.